EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Psychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?

Sylvie Binda iD, Annie Tremblay, Umar Haris Iqbal, Ola Kassem, Mélanie Le Barz, Vincent Thomas iD, Stéphane Bronner, Tara Perrot, Nafissa Ismail iD, J Alex Parker

Microorganisms · 22.03.2024 · 12 (4) · 634

DOI: 10.3390/microorganisms12040634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 22.03.2024. Verfasst von Sylvie Binda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Lallemand Health Solutions, 19 Rue des Briquetiers, BP 59, 31702 Blagnac, France. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bidirectional relationship between the gut microbiota and the nervous system is known as the microbiota–gut–brain axis (MGBA). The MGBA controls the complex interactions between the brain, the enteric nervous system, the gut-associated immune system, and the enteric neuroendocrine systems, regulating key physiological functions such as the immune response, sleep, emotions and mood, food intake, and intestinal functions. Psychobiotics are considered tools with the potential to modulate the MGBA through preventive, adjunctive, or curative approaches, but their specific mechanisms of action on many aspects of health are yet to be characterized. This narrative review and perspectives article highlights the key paradigms needing attention as the scope of potential probiotics applications in human health increases, with a growing body of evidence supporting their systemic beneficial effects. However, there are many limitations to overcome before establishing the extent to which we can incorporate probiotics in the management of neuropsychiatric disorders. Although this article uses the term probiotics in a general manner, it remains important to study probiotics at the strain level in most cases.

Schlagwörter

Stichwörter der Autor:innen

early-life stressmetabolic syndromemicrobiota–gut–brain axismicroglianeuroinflammationneuropsychiatric disordersobesitypsychobioticsstress

Autor:innen und Institutionen

  • Lallemand Health Solutions, 19 Rue des Briquetiers, BP 59, 31702 Blagnac, France.
  • Rosell Institute for Microbiome and Probiotics, Lallemand Health Solutions, 6100 Royalmount Avenue, Montreal, QC H4P 2R2, Canada.
  • Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • Department of Psychology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
  • Département de Neurosciences, Université de Montréal, Montreal, QC H3T 1J4, Canada.

ORCID-Profile: Sylvie Binda, Vincent Thomas, Nafissa Ismail

Zitieren

APA

Binda, S., Tremblay, A., Iqbal, U. H., Kassem, O., Le Barz, M., Thomas, V., Bronner, S., Perrot, T., Ismail, N., & Parker, J. A. (2024). Psychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?. Microorganisms, 12(4), 634. https://doi.org/10.3390/microorganisms12040634

Vancouver

Binda S, Tremblay A, Iqbal UH, Kassem O, Le Barz M, Thomas V, et al. Psychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?. Microorganisms. 2024;12(4):634. doi:10.3390/microorganisms12040634

BibTeX
@article{Binda2024,
  author = {Binda, Sylvie and Tremblay, Annie and Iqbal, Umar Haris and Kassem, Ola and Le Barz, Mélanie and Thomas, Vincent and Bronner, Stéphane and Perrot, Tara and Ismail, Nafissa and Parker, J Alex},
  title = {Psychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {4},
  pages = {634},
  doi = {10.3390/microorganisms12040634}
}
Kostenlos starten →